706 related articles for article (PubMed ID: 30921478)
1. Benzodiazepines versus placebo for panic disorder in adults.
Breilmann J; Girlanda F; Guaiana G; Barbui C; Cipriani A; Castellazzi M; Bighelli I; Davies SJ; Furukawa TA; Koesters M
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD010677. PubMed ID: 30921478
[TBL] [Abstract][Full Text] [Related]
2. Antidepressants versus placebo for panic disorder in adults.
Bighelli I; Castellazzi M; Cipriani A; Girlanda F; Guaiana G; Koesters M; Turrini G; Furukawa TA; Barbui C
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010676. PubMed ID: 29620793
[TBL] [Abstract][Full Text] [Related]
3. Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults.
Imai H; Tajika A; Chen P; Pompoli A; Furukawa TA
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD011170. PubMed ID: 27730622
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological treatments in panic disorder in adults: a network meta-analysis.
Guaiana G; Meader N; Barbui C; Davies SJ; Furukawa TA; Imai H; Dias S; Caldwell DM; Koesters M; Tajika A; Bighelli I; Pompoli A; Cipriani A; Dawson S; Robertson L
Cochrane Database Syst Rev; 2023 Nov; 11(11):CD012729. PubMed ID: 38014714
[TBL] [Abstract][Full Text] [Related]
5. Antidepressants and benzodiazepines for panic disorder in adults.
Bighelli I; Trespidi C; Castellazzi M; Cipriani A; Furukawa TA; Girlanda F; Guaiana G; Koesters M; Barbui C
Cochrane Database Syst Rev; 2016 Sep; 9(9):CD011567. PubMed ID: 27618521
[TBL] [Abstract][Full Text] [Related]
6. Azapirones versus placebo for panic disorder in adults.
Imai H; Tajika A; Chen P; Pompoli A; Guaiana G; Castellazzi M; Bighelli I; Girlanda F; Barbui C; Koesters M; Cipriani A; Furukawa TA
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD010828. PubMed ID: 25268297
[TBL] [Abstract][Full Text] [Related]
7. Antidepressants plus benzodiazepines for adults with major depression.
Ogawa Y; Takeshima N; Hayasaka Y; Tajika A; Watanabe N; Streiner D; Furukawa TA
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD001026. PubMed ID: 31158298
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users.
Baandrup L; Ebdrup BH; Rasmussen JØ; Lindschou J; Gluud C; Glenthøj BY
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011481. PubMed ID: 29543325
[TBL] [Abstract][Full Text] [Related]
9. Vortioxetine for depression in adults.
Koesters M; Ostuzzi G; Guaiana G; Breilmann J; Barbui C
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011520. PubMed ID: 28677828
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological interventions for somatoform disorders in adults.
Kleinstäuber M; Witthöft M; Steffanowski A; van Marwijk H; Hiller W; Lambert MJ
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010628. PubMed ID: 25379990
[TBL] [Abstract][Full Text] [Related]
11. S-adenosyl methionine (SAMe) for depression in adults.
Galizia I; Oldani L; Macritchie K; Amari E; Dougall D; Jones TN; Lam RW; Massei GJ; Yatham LN; Young AH
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD011286. PubMed ID: 27727432
[TBL] [Abstract][Full Text] [Related]
12. Antidepressants for the treatment of depression in people with cancer.
Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011006. PubMed ID: 29683474
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
Cipriani A; Reid K; Young AH; Macritchie K; Geddes J
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD003196. PubMed ID: 24132760
[TBL] [Abstract][Full Text] [Related]
14. Paroxetine versus other anti-depressive agents for depression.
Purgato M; Papola D; Gastaldon C; Trespidi C; Magni LR; Rizzo C; Furukawa TA; Watanabe N; Cipriani A; Barbui C
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD006531. PubMed ID: 24696195
[TBL] [Abstract][Full Text] [Related]
15. Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis.
Pompoli A; Furukawa TA; Imai H; Tajika A; Efthimiou O; Salanti G
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011004. PubMed ID: 27071857
[TBL] [Abstract][Full Text] [Related]
16. Early pharmacological interventions for prevention of post-traumatic stress disorder (PTSD) in individuals experiencing acute traumatic stress symptoms.
Bertolini F; Robertson L; Bisson JI; Meader N; Churchill R; Ostuzzi G; Stein DJ; Williams T; Barbui C
Cochrane Database Syst Rev; 2024 May; 5(5):CD013613. PubMed ID: 38767196
[TBL] [Abstract][Full Text] [Related]
17. Antidepressants for the treatment of depression in people with cancer.
Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011006. PubMed ID: 26029972
[TBL] [Abstract][Full Text] [Related]
18. Agomelatine versus other antidepressive agents for major depression.
Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
Cochrane Database Syst Rev; 2013 Dec; (12):CD008851. PubMed ID: 24343836
[TBL] [Abstract][Full Text] [Related]
19. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.
Olthuis JV; Watt MC; Bailey K; Hayden JA; Stewart SH
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD011565. PubMed ID: 26968204
[TBL] [Abstract][Full Text] [Related]
20. Antidepressants for the treatment of people with co-occurring depression and alcohol dependence.
Agabio R; Trogu E; Pani PP
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008581. PubMed ID: 29688573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]